Hong Kong Science and Technology Parks Corporation (HKSTP) will be leading two major overseas delegations in June—VivaTech 2026 in Paris, Europe’s leading startup showcase, and BIO International Convention (BIO) 2026 in San Diego, the world’s largest life and health technology event. The twin missions put Hong Kong innovation on a global stage at an unprecedented scale to open new paths for collaboration, investment and two-way market access for tech ventures from Hong Kong, as well as for European and US innovators seeking opportunities in Hong Kong, the Greater Bay Area (GBA) and across Asia.
HKSTP will be leading 2 major delegations to VivaTech in Paris and the BIO International Convention 2026 in San Diego within June, bringing Hong Kong innovation to the global stage and unlocking unprecedented growth opportunities.
“June marks a landmark moment in HKSTP’s mission to rally a global tech community to reinforce Hong Kong’s position as a launchpad to success, also to promote the vibrancy and sustainability of our innovation and technology (I&T) ecosystem,” said Terry Wong, CEO, HKSTP. “Our priorities lie with AI and biotech, both fields speak unmeasurable value and impact that would set us apart in this digital age, and of course, are core to connecting innovation ecosystems of the US, Europe and the Chinese Mainland as an international I&T hub.”
Click to Gallery
HKSTP will be leading 2 major delegations to VivaTech in Paris and the BIO International Convention 2026 in San Diego within June, bringing Hong Kong innovation to the global stage and unlocking unprecedented growth opportunities.
Terry Wong, CEO of HKSTP, said: “June marks a landmark moment in HKSTP’s mission to rally a global tech community to reinforce Hong Kong’s position as a launchpad to success, also to promote the vibrancy and sustainability of our innovation and technology (I&T) ecosystem.”
Antonio Ng, CEO of Formwork IO, made Top 30 of the Tech For Change Awards by VivaTech, introduced the latest ‘Matcha Tile,’ making its debut with a bio-pigment palette derived from actual matcha waste, reflecting a rapid growing market demand for the ingredient.
Herman Chan, Managing Director of LeafIoT (2nd from left) shared the concept behind its green asset management solution, was to absorb the best of both traditional Eastern diagnostics and modern AI, and analyse health risks of trees in a compact urban- or vast rural settings.
Ivan Lau, CEO of Pantheon Lab shared real-life applications and impact of its digital human interface solution, offering corporation and organisations an alternative in directing their resources more efficiently.
Dr Cynthia Shum, Business Development Manager of GenEditBio, will join HKSTP's delegation to US BIO and showcase their vivo genome editing therapies (also known as "DNA surgery").
Dr. Xia JIN, CEO and Co-Founder of Immuno Cure, shared that their first-in-class HIV therapeutic DNA vaccine, ICVAX, has completed a Phase I clinical trial with promising results. At US BIO 2026, the company will announce encouraging IIT efficacy results for ICVAX and a collaboration with a renowned corporation.
Terry Wong, CEO of HKSTP, said: “June marks a landmark moment in HKSTP’s mission to rally a global tech community to reinforce Hong Kong’s position as a launchpad to success, also to promote the vibrancy and sustainability of our innovation and technology (I&T) ecosystem.”
VivaTech 2026: A Decade of Innovation
As VivaTech celebrates its 10th year serving as a beacon to startups looking to enter Europe, HKSTP returns as a premier I&T ecosystem orchestrator, from 17 to 20 June, supporting the Hong Kong Trade Development Council (HKTDC) in organising the Hong Kong Tech Pavilion showcases innovative solutions of 24 Hong Kong tech ventures, among which 16 are incubated by HKSTP, spans AI, green- and health tech, to connect with the local I&T community, the European market, and global innovators through matching sessions, mixers, and more. Notable tech ventures include:
Antonio Ng, CEO of Formwork IO, made Top 30 of the Tech For Change Awards by VivaTech, introduced the latest ‘Matcha Tile,’ making its debut with a bio-pigment palette derived from actual matcha waste, reflecting a rapid growing market demand for the ingredient.
Formwork IO — A ClimateTech materials company that transforms upcycled industrial by-products and wellness-focused bio-pigments, into building materials that actively sequester atmospheric CO2, uniting carbon leadership, circularity, and human wellness in a single material innovation, has made Top 30 of the Tech For Change Awards by VivaTech.
Herman Chan, Managing Director of LeafIoT (2nd from left) shared the concept behind its green asset management solution, was to absorb the best of both traditional Eastern diagnostics and modern AI, and analyse health risks of trees in a compact urban- or vast rural settings.
LeafIoT — A pioneer in green asset management introducing a groundbreaking East-meets-West smart tree management system, translating the traditional Eastern diagnostics into modern AI technology to significantly extend the lifespan of trees and restore natural ecological balance in an urban setting, empowering governments and enterprises to achieve green and low-carbon goals securely.
Ivan Lau, CEO of Pantheon Lab shared real-life applications and impact of its digital human interface solution, offering corporation and organisations an alternative in directing their resources more efficiently.
Dr Cynthia Shum, Business Development Manager of GenEditBio, will join HKSTP's delegation to US BIO and showcase their vivo genome editing therapies (also known as "DNA surgery").
Pantheon Lab — A leading GenAI company providing advanced Agentic AI and digital human interface solutions span banking, public services, government agencies, and large enterprises.
BIO 2026: The largest-ever Hong Kong Biotech Debut
Showcasing growing global biotech momentum, HKSTP will organize the largest-ever Hong Kong Pavilion at BIO 2026 from 22 – 25 June, featuring double the number of participating organizations and exhibition area size compared to last year. Joining forces with InvestHK as the co-organiser, HKTDC as the supporting organisation, and five renowned local universities - The University of Hong Kong, The Chinese University of Hong Kong, The Hong Kong University of Science and Technology, City University of Hong Kong, and The Hong Kong Polytechnic University - the record-breaking delegation will showcase life and health innovation from 41 tech firms, institutes, and university spin-offs from Hong Kong. The innovation spans AI-enabled biotech, therapeutics, diagnostics, and pharma innovation, with potential outstanding "First-in-Class" and "Best-in-Class" assets.
Beyond the BIO 2026 Hong Kong Pavilion, HKSTP CEO Mr Terry Wong will attend the "Translating Innovation Across Borders: Creating Global Gateways for Biotech Startups" panel sharing session. This panel session will explore how structured programmes can create intentional pathways for international startups to integrate into leading biotech ecosystems. Mr. Wong will share his insights on cutting-edge biotech trends, Hong Kong’s strengths on life and health tech development, and HKSTP’s orchestrating role of building global bridge for nurturing global startup expansion, sustainable innovation and collaboration.
Furthermore, HKSTP will host a Global Mixer, curated pitching sessions, executive sharing and targeted networking events to open doors for commercialisation, licensing, partnerships, investment and international expansion.
Featured Hong Kong startups at BIO 2026:
GenEditBio — Specializes in developing in vivo genome editing therapies (also known as "DNA surgery") by discovering novel Cas nucleases and creating fundamentally safe, efficient and affordable in vivo delivery technologies to treat genetic mutation-related diseases.
Dr. Xia JIN, CEO and Co-Founder of Immuno Cure, shared that their first-in-class HIV therapeutic DNA vaccine, ICVAX, has completed a Phase I clinical trial with promising results. At US BIO 2026, the company will announce encouraging IIT efficacy results for ICVAX and a collaboration with a renowned corporation.
Immuno Cure — Focusing on DNA medicines and antibody immunotherapies for infectious diseases, inflammation, and cancers. First-in-class HIV therapeutic DNA vaccine, ICVAX, completed Phase I clinical trial with promising results, and soon enters Phase II clinical trial. Pipeline products also include DNA vaccines and antibody against various cancers are underway in preclinical stage.
Through these missions, HKSTP is not only taking home-grown innovators overseas, but also attracting partners, capital, talent and collaboration into Hong Kong. The goal is clear: position Hong Kong as a super-connector for local startups to access the vast opportunities in markets across the world, vice versa, and to accentuate that momentum into a model of influence.
Hong Kong Science and Technology Parks Corporation (HKSTP), in partnership with German Industry and Commerce (GIC) and ADVANTAGE AUSTRIA, and supported by the Innovation, Technology and Industry Bureau, InvestHK and HKETO Berlin, led a delegation of eight Hong Kong Science Park companies to Germany and Austria from 21 to 25 September 2026 for a focused programme of business matching, ecosystem exchange and institutional engagement across Munich, Vienna and Graz. Bringing together government, industry, academia and innovation ecosystem partners, the mission deepened engagement with leading stakeholders, created new opportunities for cross-border collaboration and commercialisation in artificial intelligence (AI), new industralisation, and smart city, and reinforced Hong Kong’s role as a preferred platform for innovation exchange between Europe and Asia.
The high potential tech firms continued the week-long journey in Vienna and Graz, connected with leading Austrian research, industry and innovation organisations.
The high potential tech firms continued the week-long journey in Vienna and Graz, connected with leading Austrian research, industry and innovation organisations.
The delegation marked a major step forward in HKSTP’s growing engagement in Central Europe. As HKSTP’s first market-focused mission to Germany, Europe’s largest AI market and a leading enterprise technology hub, it built on earlier collaboration with ADVANTAGE AUSTRIA, including GO AUSTRIA Spring 2025 and 2026 and the renowned ViennaUP Festival, as well as more recent joint efforts with partners in Germany and Austria under Global Connect and the Global Innovation Exchange. The ongoing efforts created practical pathways for Hong Kong companies to explore partnerships, validate demand and expand into key European markets.
Professor Sun Dong, Secretary for Innovation, Technology and Industry, delivered a speech at the Applied Artificial Intelligence Conference 2026 (AAIC) in Vienna, Austria. He had an exchange with the HKSTP delegation to learn about their innovative solutions.
A key highlight was HKSTP’s participation in the Applied Artificial Intelligence Conference 2026 (AAIC) in Vienna, Austria, to connect with key industry partners and investors for potential business collaboration. Professor Sun Dong, Secretary for Innovation, Technology and Industry, delivered a speech titled “AAIC-Talk: Applied AI in Hong Kong and the Greater Bay Area: Innovation, Industrial Transformation and Opportunities for Collaboration with Austria” at the Austria’s flagship international AI business conference. He shared Hong Kong has elevated AI into a core industry and is emerging as one of the world's most dynamic innovation and technology (I&T) centres. He also invited Austria to partner in shaping AI's next chapter, and highlighting opportunities for collaboration between Hong Kong, the Greater Bay Area and Austria. During the Conference, Professor Sun had a brief exchange with park companies from the delegation participating in the Conference to learn about their innovative solutions.
Professor Sun Dong, Secretary for Innovation, Technology and Industry, delivered a speech at the Applied Artificial Intelligence Conference 2026 (AAIC) in Vienna, Austria. He had an exchange with the HKSTP delegation to learn about their innovative solutions.
Mr Eric Or, Chief Ecosystem Development Officer of HKSTP, said, “HKSTP is committed to helping innovators scale beyond borders. Our inaugural delegation to Germany and the continuous connection with Austria highlights the value of strategic international engagement in opening doors for park companies to connect with leading industry, academic and investors in Europe. It also reflects Hong Kong’s unique role as a gateway for cross-border collaboration, underpinned by its distinct strengths as a super-connector and super value-adder. As HKSTP continues to expand its global outreach to further strengthen Hong Kong’s innovation links with global markets, and reinforce the city’s position as an international innovation and technology hub.”
The delegation began in Munich and visited the Chamber of commerce and industry for Munich and upper Bavaria (IHK).
The delegation began in Munich, focusing on Germany’s industrial AI and enterprise innovation ecosystem, and engaging institutions including Chamber of commerce and industry for Munich and upper Bavaria (IHK), Siemens AI Lab, and the European Union’s top Technical University of Munich (TUM). Discussions centred on industrial AI, advanced manufacturing, technology translation and cross-border collaboration. The high potential tech firms continued the week long journey in Vienna and Graz, connected with leading Austrian research, industry and innovation organisations, including the leading Graz University of Technology (TU Graz), Austrian Institute of Technology and more.
The delegation began in Munich and visited the Chamber of commerce and industry for Munich and upper Bavaria (IHK).
Highlighted innovations from the delegation:
GenAI-Powered Marketing - Amber International Holding Limited introduced MIA, its new agentic AI marketing platform designed to monitor markets, generate on-brand content and support distribution workflows with human approval.
Amber International Holding Limited introduced MIA, its new agentic AI marketing platform designed to monitor markets, generate on-brand content and support distribution workflows with human approval.
Let AI run enterprises. Let AI do business - Echronos AI Group, a China-based innovator in industrial-grade AI Agentic OS, leverages the HKSTP ecosystem and Hong Kong’s global connectivity as a gateway for international expansion. The company introduced its flagship JovaAI platform to European industry leaders. Powered by proprietary semantic and multi-agent orchestration technologies, JovaAI coordinates complex enterprise workflows, from inquiry-to quote orchestration and cross-border customs planning to dynamic production rescheduling.
Echronos AI Group, a China-based innovator in industrial-grade AI Agentic OS, leverages the HKSTP ecosystem and Hong Kong’s global connectivity as a gateway for international expansion.
End-to-end AI Talent Solution - Neufast offers corporate AI strategy consulting and technical implementation for an agentic AI platform covering candidate sourcing, performance appraisals, and leadership development. It is expanding in Europe through partnerships with SAP SuccessFactors for enterprise business transformation and TÜV Rheinland for ISO27001 certification, with the support of the Austrian government’s Go Austria Plus programme by the Global Incubator Network Austria (GIN) and Austrian Research Promotion Agency (FFG).
Neufast offers corporate AI strategy consulting and technical implementation for an agentic AI platform covering candidate sourcing, performance appraisals, and leadership development. It is expanding in Europe through participating in various programmes.
Together, these engagements in Germany and Austria deepened HKSTP’s ties with the regions’ innovation ecosystem and opened new opportunities for collaboration in applied AI, robotics, smart production and commercialisation between Hong Kong and Europe.